Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria

Clinical Microbiology Reviews

Volumn 15, Issue 4, 2002, Pages 716-746

  Brown Elliott, Barbara A ^a   Wallace Jr , Richard J ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

COMMUNICABLE DISEASE; HEALTH CARE; HUMAN; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM PEREGRINUM; MYCOBACTERIUM SMEGMATIS; REVIEW; TAXONOMY; ATYPICAL MYCOBACTERIOSIS; CATHETERIZATION; CLASSIFICATION; DRUG EFFECT; GENETICS; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; OCCUPATIONAL DISEASE; SKIN INFECTION; WOUND INFECTION;

CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM PEREGRINUM; MYCOBACTERIUM SMEGMATIS;

ANTI-BACTERIAL AGENTS; CATHETERIZATION; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM SMEGMATIS; OCCUPATIONAL DISEASES; SKIN DISEASES, INFECTIOUS; WOUND INFECTION;

EID: 0036781756     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.15.4.716-746.2002     Document Type: Review

References (229)

1. Al Shaalan, M., B. J. Law, S. J. Israels, P. Pianosi, A. G. Lacson, and R. Higgins. 1997. Mycobacterium fortuitum interstitial pneumonia with vasculitis in a child with Wilms' tumor. Pediatr. Infect. Dis. J. 16:996-1000.
2. Austin, W. K., and M. W. Lockey. 1976. Mycobacterium fortuitum mastoiditis. Arch Otolaryngol. 102:558-560.
3. Awe, R. J., P. R. Gangadharam, and D. E. Jenkins. 1973. Clinical significance of Mycobacterium fortuitum infections in pulmonary disease. Am. Rev. Respir. Dis. 108:1230-1234.
4. Azadian, B. S., A. Beck, J. R. Curtis, L. E. Cherrington, P. E. Cower, M. Phillips, J. B. Eastwood, and J. Nicholls. 1981. Disseminated infection with Mycobacterium chelonei in a haemodialysis patient. Tubercle 62:281-284.
5. Band, J. D., J. I. Ward, D. W. Fraser, N. J. Peterson, V. A. Silcox, R. C. Good, P. R. Ostrey, and J. Kennedy. 1982. Peritonitis due to a Mycobacterium chelonei-like organism associated with intermittent chronic peritoneal dialysis. J. Infect. Dis. 145:9-17.
6. Bange, F.-C., B. A. Brown, C. Smaczny, R. J. Wallace Jr., and E. C. Böttger. 2001. Lack of transmission of Mycobacterium abscessus among patients with cystic fibrosis attending a single clinic. Clin. Infect. Dis. 32:1648-1650.
7. Bascuñana, C. R., and K. Belák. 1996. Detection and identification of mycobacteria in formalin-fixed, paraffin-embedded tissues by nested PCR and restriction enzyme analysis. J. Clin. Microbiol. 34:2351-2355.
8. Biehle, J. R., S. J. Cavalieri, M. A. Saubolle, and L. J. Getsinger. 1995. Evaluation of Etest for susceptibility testing of rapidly growing mycobacteria. J. Clin. Microbiol. 33:1760-1764.
9. Blacklock, Z. M., and D. J. Dawson. 1979. Atypical mycobacteria causing non-pulmonary disease in Queensland. Pathology 11:283-287.
10. Bojalil, L. F., and J. Cerbón. 1961. Taxonomic analysis of nonpigmented, rapidly growing mycobacteria. J. Bacteriol. 81:338-345.
11. Bojalil, L. F., J. Cerbón, and A. Trujillo. 1962. Adansonian classification of mycobacteria. J. Gen. Microbiol. 28:333-346.
12. Bolan, G., A. L. Reingold, L. A. Carson, V. A. Silcox, C. L. Woodley, P. S. Hayes, A. W. Hightower, L. McFarland, J. W. Brown III, N. J. Petersen, M. S. Favero, R. C. Good, and C. V. Broome. 1985. Infections with Mycobacterium chelonei in patients receiving dialysis and using processed hemodialyzers. J. Infect. Dis. 152:1013-1019.
13. Bōnicke, R. 1966. The occurrence of atypical mycobacteria in the environment of man and animal. Bull. Int. Union Tuberc. Lung Dis. 37:361-368.
14. Booth, J. E., J. A. Jacobson, T. A. Kurrus, and T. W. Edwards. 1979. Infection of prosthetic arthroplasty by M. fortuitum. Two case reports. J. Bone Joint Surg. 61A:300.
15. Borghaus, J. G. A., and J. L. Stanford. 1973. Mycobacterium chelonei in abscesses after injection of diphtheria-pertussis-tetanus-polio vaccine. Am. Rev. Respir. Dis. 107:1-8.
16. Brannan, D. P., R. E. DuBois, M. J. Ramirez, M. J. R. Ravry, and E. O. Harrison. 1984. Cefoxitin therapy for Mycobacterium fortuitum bacteremia with associated granulomatous hepatitis. South. Med. J. 77:381-382.
17. Brown, B. A., B. Springer, V. A. Steingrube, R. W. Wilson, G. E. Pfyffer, M. J. Garcia, M. C. Menendez, B. Rodriguez-Salgado, K. C. Jost, S. H. Chiu, G. O. Onji, E. C. Böttger, and R. J. Wallace, Jr. 1999. Description of Mycobacterium wolinskyi and Mycobacterium goodii, two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial Taxonomy. Int. J. Syst. Bacteriol. 49:1493-1511.
18. Brown, B. A., J. M. Swenson, and R. J. Wallace Jr. 1992. Agar disk elution test for rapidly growing mycobacteria, p. 5.10.1-5.10.11. In H. D. Isenberg (ed.), Clinical microbiology procedures handbook, section 5: antimicrobial susceptibility testing, vol. 1. American Society for Microbiology, Washington, D.C.
19. Brown, B. A., J. M. Swenson, and R. J. Wallace, Jr. 1992. Broth microdilution MIC test for rapidly growing mycobacteria, p. 5.11.1-5.11.9. In H. D. Isenberg (ed.), Clinical microbiology procedures handbook, section 5: antimicrobial susceptibility testing, vol. 1. American Society for Microbiology Washington, D.C.
20. Brown, B. A., R. J. Wallace, Jr., G. Onji, V. DeRosas, and R. J. Wallace III. 1992. Activities of four macrolides including clarithromycin against Mycobacterium fortuitum, Mycobacterium chelonae, and Mycobacterium chelonae-like organisms. Antimicrob. Agents Chemother. 36:180-184.
21. Brown-Elliott, B. A., R. J. Wallace Jr., R. Blinkhorn, C. J. Crist, and L. M. Mann. 2001. Successful treatment of disseminated Mycobacterium chelonae infection with linezolid. Clin. Infect. Dis. 33:1433-1434.
22. Buckley, R., M. W. Cobb, S. Ghurani, N. F. Brock, and R. R. Harford. 1997. Mycobacterium fortuitum infection occurring after a punch biopsy procedure. Pediatr. Dermatol. 14:290-292.
23. Bullington, R. H., J. D. Lanier, and R. L. Font. 1992. Nontuberculous mycobacterial keratitis. Arch. Ophthalmol. 110:519-524.
24. Burns, D. N., P. K. Rohatgi, R. Rosenthal, M. Seiler, and F. M. Gordin. 1990. Disseminated Mycobacterium fortuitum successfully treated with combination therapy including ciprofloxacin. Am. Rev. Respir. Dis. 142:468-470.
25. Burns, D. N., R. J. Wallace, Jr., M. E. Schultz, V. Zhang, S. Q. Zubairi, Y. Pang, C. L. Gibert, B. A. Brown, E. S. Noel, and F. M. Gordin 1991. Nosocomial outbreak of respiratory tract colonization with Mycobacterium fortuitum: demonstration of the usefulness of pulsed-field gel electrophoresis in an epidemiologic investigation. Am. Rev. Respir. Dis. 144:1153-1159.
26. Burns, J. L., U. Malhotra, J. Lingappa, and S. Smith. 1997. Unusual presentations of nontuberculous mycobacterial infections in children. Pediatr. Infect. Dis. J. 16:802-806.
27. Butler, W. R., and J. O. Kilburn. 1990. High-performance liquid chromatography patterns of mycolic acids as criteria for identification of Mycobacterium chelonac, Mycobacterium fortuitum, and Mycobacterium smegmatis. 3. Clin. Microbiol. 28:2094-2098.
28. Butt, A. A. 1998. Cervical adenitis due to Mycobacterium fortuitum in patients with acquired immunodeficiency syndrome. Am. J. Med. Sci. 315:50-55.
29. Campagnaro, R. L., H. Teichtahl, and B. Dwyer. 1994. A pseudoepidemic of Mycobacterium chelonae: contamination of a bronchoscope and auto-cleaner. Aust. N. Z. J. Med. 24:693-695.
30. Carmago, D., C. Saad, F. Ruiz, M. E. Ramirez, M. Lineros, G. Rodriguez, E. Navarro, B. Pulido, and L. C. I. Orozco. 1996. Iatrogenic outbreak of M. chelonae skin abscesses. Epidemiol. Infect. 117:113-119.
31. Carson, L. A., L. B. Cusick, L. A. Bland, and M. S. Favero. 1988. Efficacy of chemical dosing methods for isolating nontuberculous mycobacteria from water supplies of dialysis centers. Appl. Environ. Microbiol. 54:1756-1760.
32. Cegielski, J. P., and R. J. Wallace Jr. 1997. Infections due to nontuberculous mycobacteria, p. 445-461. In W. M. Scheld, R. J. Whitley, and D. T. Durack (ed.), Infections of the central nervous system, 2nd ed., Lippincott-Raven Publishers, Philadelphia, Pa.
33. Centers for Disease Control and Prevention. 1996. Infection with Mycobacterium abscessus associated with intramuscular injection of adrenal cortex extract-Colorado and Wyoming, 1995-1996. Morb. Mortal. Wkly. Rev. 45:713-715.
34. Chamoiseau, G. 1979. Etiology of farcy in African bovines: nomenclature of the causal organisms Mycobacterium farcinogenes Chamoiseau and Mycobacterium senegalense (Chamoiseau) comb. nov. Int. J. Syst. Bacteriol. 29:407-410.
35. Chang, M. J., and L. L. Barton. 1974. Mycobacterium fortuitum osteomyelitis of the calcaneus secondary to a puncture wound. J. Pediatr. 85:517-519.
36. Chetchotisakd, P., P. Mootsikapun, S. Anunnatsiri, K. Jirarattanapochai, C. Choonhakarn, A. Chaiprasert, P. N. Ubol, L. J. Wheat, and T. E. Davis. 2000. Disseminated infection due to rapidly growing mycobacteria in immunocompetent hosts presenting with chronic lymphadenopathy: a previously unrecognized clinical entity. Clin. Infect. Dis. 32:29-34.
37. Choueiry, M. A., P. L. Scurto, P. M. Flynn, B. N. Rao, and W. T. Hughes. 1998. Disseminated infection due to Mycobacterium fortuitum in a patient with desmoid tumor. Clin. Infect. Dis. 26:237-238.
38. Clegg, H. W., M. T. Foster, W. E. Sanders, Jr., and W. B. Baine. 1983. Infection due to organisms of the Mycobacterium fortuitum complex after augmentation mammaplasty: clinical and epidemiologic features. J. Infect. Dis. 147:427-133.
39. 38a. Conville, P. S., and F. G. Witebsky. 2001. Lack of usefulness of carbon utilization tests for identification of Mycobacterium mucogenicum. J. Clin. Microbiol. 39:2725-2728.
40. Covert, T. C., M. R. Rodgers, A. L. Reyes, and G. N. Stelma, Jr. 1999. Occurrence of nontuberculous mycobacteria in environmental samples. Appl. Environ. Microbiol. 65:2492-2496.
41. Cullen, A. R., C. L. Cannon, E. J. Mark, and A. A. Colin. 2000. Mycobacterium abscessus infection in cystic fibrosis. Am J. Respir. Crit. Care Med. 161:641-645.
42. Cutay, A. M., H. W. Horowitz, R. W. Pooley, K. Van Horn, and G. P. Wormser. 1998. Infection of epicardial pacemaker wires due to Mycobacterium abscessus. Clin. Infect. Dis. 26:520-521.
43. da Costa Cruz, J. C. 1938. Mycobacterium fortuitum: um novo bacilo acido-resistente patogenico para o homen (new acid fast bacillus pathogenic for man). Acta Med. (Rio de Jåneiro) 1:298-301.
44. Dalovisio, J. R., G. A. Pankey, R. J. Wallace, Jr., and D. B. Jones. 1981. Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei. Rev. Infect. Dis. 3:1068-1074.
45. De Beenhouwer, H., Z. Liang, P. de Rijk, C. van Eekeren, and F. Portaels. 1995. Detection and identification of mycobacteria by DNA amplification and oligonucleotide-specific capture plate hybridization. J. Clin. Microbiol. 33:2994-2998.
46. Devallois, A., K. S. Goh, and N. Rastogi. 1997. Rapid identification of mycobacteria to species level by PCR-restriction fragment length polymorphism analysis of the hsp65 gene and proposition of an algorithm to differentiate 34 mycobacterial species. J. Clin. Microbiol. 35:2969-2973.
47. Domenech, P., M. S. Jimenez, M. C. Menendez, T. J. Bull, S. Samper, A. Manrique, and M. J. Garcia. 1984. Mycobacterium mageritense sp. nov. Int. J. Syst. Bacteriol. 47:535-540.
48. Efthimiou, J., M. J. Smith, M. E. Hudson, and J. C. Batten. 1984. Fatal pulmonary infection with Mycobacterium fortuitum in cystic fibrosis. Br. J. Dis. Chest 78:299-302.
49. Fauroux, B., B. Delaisi, A. Clément, C. Saizou, D. Moissenet, C. Truffot-Pernot, G. Tournier, and II. Vu Thien. 1997. Mycobacterial lung disease in cystic fibrosis: a prospective study. Pediatr. Infect. Dis. J. 16:354-358.
50. Ferraro, M. J., W. A. Craig, G. Eliopoulos, J. Fung-Tomc, S. L. Hansen, D. W. Hecht, J. Hindler, L. B. Relier, D. F. Sahm, J. M. Swenson, F. C. Tenover, R. T. Testa, and M. A. Wikler. 1998. Performance standards for antimicrobial susceptibility testing; eighth informational supplement. Standard M100-S8. NCCLS, Wayne, Pa.
51. Flor, A., J. A. Capdevila, N. Martin, J. Gavaldà, and A. Pahissa. 1996. Nontuberculous mycobacterial meningitis: report of two cases and review. Clin. Infect. Dis. 23:1266-1273.
52. Flynn, P. M., B. Van Hooser, and F. Gigliotti. 1988. Atypical mycobacterial infections of Hickman catheter exit sites. Pediatr. Infect. Dis. J. 7:510-513.
53. Foz, A., C. Roy, J. Jurado, E. Arteaga, J. M. Ruiz, and A. Moragas. 1978. Mycobacterium chelonei iatrogenic infections. J. Clin. Microbiol. 7:319-321.
54. Franklin, D. J, J. R. Starke, M. T. Brady, B. A. Brown, and R. J. Wallace, Jr. Chronic otitis media after tympanostomy tube placement caused by Mycobacterium abscessus: a new clinical entity? Am. J. Otol. 15:313-320.
55. Fraser, V. J., M. Jones, P. R. Murray, G. Medoff, Y. Zhang, and R. J. Wallace, Jr. 1992. Contamination of flexible fiberoptic bronchoscopes with Mycobacterium chelonae linked to an automated bronchoscope disinfection machine. Am. Rev. Respir. Dis. 145:853-855.
56. Fraser, V., and R. J. Wallace, Jr. 1996. Nontuberculous mycobacteria, p. 1224. in C. G. Mayhall (ed.), Hospital epidemiology and infection control. The Williams & Wilkins Co., Baltimore, Md.
57. Friedman, N. D., and D. J. Sexton. 2001. Bursitis due to Mycobacterium goodii, a recently described, rapidly growing mycobacterium. J. Clin. Microbiol. 39:404-t05.
58. Galil, K., L. A. Miller, M. A. Yakrus, R. J. Wallace Jr., D. G. Mosley, B. England, G. Huitt G, M. M. McNeill, and B. A. Perkins. 1999. Abscesses due to Mycobacterium abscessus linked to injection of unapproved alternative medication. Emerg. Infect. Dis. 5:681-687.
59. Gangadharam, P. R. J., J. D. Lanier, D. E. Jones. 1978. Keratitis due to Mycobacterium chelonei. Tubercle 59:55-60.
60. Georgia Department of Human Resources. 1990. Abscesses in an allergy practice due to M. chelonae. Georgia Epidemiol. Rep. 6:2.
61. Ghossein, R. A., D. G. Ross, R. N. Salmon, and A. R. Rabson. 1992. Rapid detection and species identification of mycobacteria in paraffin-embedded tissues by polymerase chain reaction. Diagn. Mol. Pathol. 1:185-191.
62. Goldblatt, M. R., and J. A. Ribes. 2002. Mycobacterium mucogenicum isolated from a patient with granulomatous hepatitis. Arch. Pathol. Lab. Med. 126:73-75.
63. Gremillion, D. H., S. B. Mursch, and C. J. Lerner. 1983. Injection site abscesses caused by Mcobacterium chelonei. Infect. Control 4:25-28.
64. Griffith, D. E., W. M. Girard, and R. J. Wallace, Jr. 1993. Clinical features of pulmonary disease caused by rapidly growing mycobacteria: analysis of 154 patients. Am. Rev. Respir. Dis. 147:1271-1278.
65. Griffith, D. E., and R. J. Wallace, Jr. 1988. Pulmonary disease due to rapidly growing mycobacteria. Semin. Respir. Med. 9:505-513.
66. Grigg, J., L. W. Hirst, M. Whitby, K. Stallard, and P. Gnanaharan. 1992. Atypical Mycobacterium keratitis. Aust. N. Z. J. Opthalmol. 20:257-261.
67. Gubler, J. G. H., M. Salfinger, and A. von Graevenitz. 1992. Pseudoepidemic of nontuberculous mycobacteria due to a contaminated bronchoscope cleaning machine: report of an outbreak and review of the literature. Chest 101:1245-1249.
68. Gyimesi, Z. S., I. H. Stalls, J. M. Miller, and C. O. Thoen. 1999. Detection of Mycobacterium avium subspecies avium in formalin-fixed, paraffin-embedded tissues of captive exotic birds using polymerase chain reaction. J. Zoo Wild. Med. 30:348-353.
69. Hand, W. L., and J. P. Sanford. 1970. Mycobacterium fortuitum-a human pathogen. Ann. Intern. Med. 73:971-977.
70. Hajes, P. S., D. L. McGiboney, J. D. Band, and J. C. Feeley. 1982. Resistance of Mycobacterium chelonei-like organisms to formaldehyde. Appl. Environ. Microbiol. 43:722-724.
71. Hector, J. S. R., Y. Pang, G. H. Mazurek, Y. Zhang, B. A. Brown, and R. J. Wallace, Jr. 1992. Large restriction fragment patterns of genomic Mycobacterium fortuitum DNA as strain-specific markers and their use in epidemiologic investigation of four nosocomial outbreaks. J. Clin. Microbiol. 30:1250-1255.
72. Herold, R. C., P. A. Lotke, and R. R. MacGregor. 1987. Prosthetic joint infections secondary to rapidly growing Mycobacterium fortuitum. Clin. Orthop. Relat. Res. 216:183-187.
73. Hoffman, P. C., D. W. Fraser, F. Robiesek, P. R. O'Bar, and C. U. Mauney. 1981. Two outbreaks of sternal wound infections due to organisms of the Mycobacterium fortuitum complex. J. Infect. Dis. 1-43:533-542.
74. Hoffner, S. E., L. Klintz, B. Olsson-Lijequist, and A. Bolmström. 1994. Evaluation of Etest for rapidly growing susceptibility testing of Mycobacterium chelonae and M. fortuitum. J. Clin. Microbiol. 32:1846-1849.
75. Hogg, G. G., M. F. Schinsky, M. M. McNeil, B. A. Lasker, V. A. Silcox, and J. M. Brown. 1994. Central line sepsis in a child due to a previously unidentified mycobacterium. J. Clin. Microbiol. 37:1193-1196.
76. Horsburgh, C. R., and R. M. Selik. 1989. The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). Am. Rev. Respir. Dis. 139:4-7.
77. Hoy, J., K. Rolston, and R. L. Hopfer. 1987. Pseudoepidemic of Mycobacterium fortuitum in bone marrow cultures. Am. J. Infect. Control 15:268-271.
78. Hoy, J. F., K. V. I. Rolston, R. L. Hopfer, and G. P. Bodey. 1987. Mycobacterium fortuitum bacteremia in patients with cancer and long-term venous catheters. Am. J. Med. 83:213-217.
79. Ichiyama, S., and M. Tsukamura. 1987. Ofloxacin and the treatment of pulmonary disease due to Mycobacterium fortuitum. Chest 92:1110-1112.
80. Jackson, P. G., H. Keen, C. J. Noble, and N. A. Simmons. 1981. Injection abscesses due to Mycobacterium chelonei occurring in a diabetic patient. Tubercle 62:277-279.
81. Jarvis, W. R., and the Epidemiology Branch, Hospital Infections Program. 1991. Nosocomial outbreaks: the Centers for Disease Control's Hospital Infections Program Experience, 1980-1990. Am. J. Med. 91(Suppl. 3B):101S.
82. Kelley, L. C., K. C. Deering, and E. T. Kaye. 1995. Cutaneous Mycobacterium chelonei presenting in an immunocompetent host: case report and feview of the literature. Cutis 56:293-295.
83. Khooshabeh, R., J. M. Grange, M. D. Yates, A. C. E. McCartney, and T. A. Casey. 1994. A case report of Mycobacterium chelonae keratitis and a review of mycobacterial infections of the eye and orbit. Tubercle Lung Dis. 75:377-382.
84. Kilby, J. M, P. H. Gilligan, J. R. Yankaskas, W. E. Highsmith, Jr., L. J. Edwards, and M. R. Knowles. 1992. Nontuberculous mycobacteria in adult patients with cystic fibrosis. Chest 102:70-75.
85. Kirschner, P., M. Kiekenbeck, D. Meissner, J. Wollers, and E. C. Bōttger. 1992. Genetic heterogeneity within Mycobacterium fortuitum complex species: genotypic criteria for identification. J. Clin. Microbiol. 30:2772-2775.
86. Koontz, F. P., M. E. Erwin, M. S. Barrett, and R. N. Jones. 1994. Etest for routine clinical antimicrobial susceptibility testing of rapidly-growing mycobacteria isolates. Diagn. Microbiol. Infect. Dis. 19:183-186.
87. Kubica, G. P., I. Baess, R. E. Gordon, P. A. Jenkins, J. B. G. Kwapinski, C. McDurmont, S. R. Pattyn, H. Saito, V. Silcox, J. L. Stanford, K. Takeya, and M. Tsukamura. 1972. A co-operative numerical analysis of rapidly growing mycobacteria. J. Gen. Microbiol. 73:55-70.
88. Kuritsky, J. N., M. G. Bullen, C. V. Broome, V. A. Silcox, R. C. Good, and R. J. Wallace Jr. 1983. Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex. Ann. Intern. Med. 98:938-939.
89. Küster, E. 1905. Ueber kaltblutertuberkulose. Muench. Med. Wochenschr. 57:57-59.
90. Kusunoki, S., and T. Ezaki. 1992. Proposal of Mycobacterium peregrinum sp. nov., nom. rev., and elevation of Mycobacterium chelonae subsp. abscessus (Kubica et al.) to species status: Mycobacterium abscessus comb. nov. Int. J. Syst. Bacteriol. 42:240-245.
91. Lai, K. K., B. A. Brown, J. A. Westerling, S. A, Fontecchio, Y. Zhang, and R. J. Wallace, Jr. 1998. Long-term laboratory contamination by Mycobacterium abscessus resulting in two pseudo-outbreaks: recognition with use of random amplified polymorphic DNA (RAPD) polymerase chain reaction. Clin. Infect. Dis. 27:169-175.
92. Lakshmi, V., R. R. Rao, and I. Dinakar. 1993. Bacteriology of brain abscess-observations on 50 cases. J. Med. Microbiol. 38:187-190.
93. Lauring, L. M., F. L. Wergeland, and G. E. Sack. 1969. Anonymous Mycobacterium keratitis. Am. J. Ophthalmol. 67:130-133.
94. Laussucq, S., A. L. Baltch, R. P. Smith, R. W. Smithwick, B. J. Davis, E. K. Desjardin, V. A. Silcox, A. B. Spellacy, R. T. Zeimis, H. M. Gruft, R. C. Good, and M. L. Cohen. 1988. Nosocomial Mycobacterium fortuitum colonization from a contaminated ice machine. Am. Rev. Respir. Dis. 138:891-894.
95. Levendoglu-Tugal, O., J. Munoz, A. Brudnicki, M. F. Ozkaynak, C. Sandoval, and S. Jayabose. 1998. Infections due to nontuberculous mycobacteria in children with leukemia. Clin. Infect. Dis. 27:1227-1230.
96. Lévy-Frébault, V., M. Daffé, K. S. Goh, M. A. Lanéelle, C. Asselineau, and H. L. David. 1983. Identification of Mycobacterium fortuitum and Mycobacterium chelonei. J. Clin. Microbiol. 17:744-752.
97. Lévy-Frébault, V., F. Grimont, P. A. D. Grimont, and H. L. David. 1986. Deoxyribonucleic acid relatedness study of the Mycobacterium fortuitum-Mycobacterium chelonae complex. Int. J. Syst. Bacteriol. 36:458-460.
98. Lowry, P. W., C. M. Beck-Sague, L. A. Bland, S. M. Aguero, M. J. Arduino, A. N. Minuth, R. A. Murray, J. M. Swenson, and W. R. Janis. 1990. Mycobacterium chelonae infection among patients receiving high-flux dialysis in a hemodialysis clinic in California. J. Infect. Dis. 161:85-90.
99. Lowry, P. W., W. R. Jarvis, A. D. Oberle, L. A. Bland, R. Silberman, J. A. Bocchini Jr., H. D. Dean, J. M. Swenson, and R. J. Wallace, Jr. 1988. Mycobacterium chelonae causing otitis media in an ear-nose-and-throat practice. N. Engl. J. Med. 319:978-982.
100. Lustgarten, S. 1885. The bacillus of syphilis. Lancet i:609-610.
101. Maloney, S., S. Welbel, B. Daves, K. Adams, S. Becker, L. Bland, M. Arduino, R. J. Wallace, Jr., Y. Zhang, G. Buck, P. Risch, and W. Jarvis. 1994. Mycobacterium abscessus pseudoinfection traced to an automated endoscope washer: utility of epidemiologic and laboratory investigation. J. Infect. Dis. 169:1166-1169.
102. Marchetti, G., A. Gori, L. Catozzi, L. Vago, M. Nebuloni, M. C. Rossi, A. D. Esposti, A. Bandera, and F. Franzetti. 1998. Evaluation of PCR in detection of Mycobacterium tuberculosis from formalin-fixed, paraffin-embedded tissues: comparison of four amplification assays. J. Clin. Microbiol. 36:1512-1517.
103. Maxson, S., G. E. Schutze, and R. F. Jacobs. 1994. Mycobacterium abscessus osteomyelitis: treatment with clarithromycin. Infect. Dis. Clin. Pract. 3:203-204.
104. McClellan, K. A., P. J. Bernard, L. P. Robinson, K. V. Meades, G. W. Aylward, and F. A. Billson. 1989. Atypical mycobacterial keratitis. Aust. N. Z. J. Ophthalmol. 17:103-105.
105. McWhinney, P. H. M., M. Yates, H. G. Prentice, M. Thrussell, S. H. Gillespie, and C. C. Kibbler. 1992. Infection caused by Mycobacterium chelonae: a diagnostic and therapeutic problem in the neutropenic patient. Clin. Infect. Dis. 14:1208-1212.
106. Meisler, D. M., M. H. Friedlaender, and M. Okumoto. 1982. Mycobacterium chelonei keratitis. Am. J. Ophthalmol. 94:398-401.
107. Meredith, F. T., and D. J. Sexton. 1996. Mycobacterium abscessus osteomyelitis following a plantar puncture wound. Clin. Infect. Dis. 23:651-653.
108. Metcalf, J. F., J. F. John, Jr., G. B. Wilson, H. H. Fudenberg, and R. A. Harley. 1981. Mycobacterium fortuitum pulmonary infection associated with an antigen-selective defect in cellular immunity. Am. J. Med. 71:485-492.
109. 107a. Meyers, H., B. A. Brown-Elliott, D. Moore, J. Curry, C. Truong, Y. Zhang, and R. J. Wallace, Jr. 2002. An outbreak of Mycobacterium chelonae following liposuction. Clin. Infect. Dis. 34:1500-1507.
110. Mirate, D. J., D. S. Hull, J. H. Steel, Jr., and M. J. Carter. 1983. Mycobacterium chelonei keratitis: a case report. Br. J. Ophthalmol. 67:324-326.
111. Miron, D., E. A. Lev, M. Zuker, D. Lumelsky, M. Murph, M. M. Floyd, and J. M. Brown. 2000. Mycobacterium fortuitum osteomyelitis of the cuboid after nail puncture wound. Pediatr. Infect. Dis. J. 19:483-485.
112. Moore, J. S., M. Christensen, R. W. Wilson, R. J. Wallace, Jr., Y. Zhang, D. R. Nash, and B. Shelton. 2000. Mycobacterial contamination of metal-working fluids: involvement of a possible new taxon of rapidly growing mycobacteria. Am. Ind. Hyg. Assoc. J. 61:205-213.
113. Moore, M., and J. B. Frerichs. 1953. An unusual acid fast infection of the knee with subcutaneous, abscess-like lesions of the gluteal region: report of a case study with a study of the organism, Mycobacterium abscessus. J. Investig. Dermatol. 20:133-169.
114. NCCLS. 2001. Performance standards for antimicrobial susceptibility testing. Eleventh informational supplement, M100-S11. NCCLS, Wayne, Pa.
115. Newton, J. A., Jr., P. J. Weiss, W. A. Bowler, and E. C. Oldfield III. 1993. Soft-tissue infection due to Mycobacterium smegmatis: report of two cases. Clin. Infect. Dis. 16:531-533.
116. Ninet, B., O. Rutschmann, K. Burkhardt, C. Metral, B. Borisch, B. Hirschel, and the Swiss HIV Cohort Study. 1999. Detection of mycobacterial nucleic acids by polymerase chain reaction in fixed tissue specimens of patients with human immunodeficiency virus infection. Diagn. Mol. Pathol. 8:145-151.
117. Nolan, C. M., P. A. Hashisaki, and D. F. Dundas. 1991. An outbreak of soft-tissued infections due to Mycobacterium fortuitum associated with electromyography. J. Infect. Dis. 163:1150-1153.
118. Nye, K., D. K. Chadha, P. Hodgkin, C. Bradley, J. Hancox, and R. Wise. 1990. Mycobacterium chelonei isolation from broncho-alveolar lavage fluid and its practical implications. J. Hosp. Infect. 16:257-261.
119. O'Brien, R. J., L. J. Geiter, and D. E. Snider. 1987. The epidemiology of nontuberculous mycobacterial diseases in the United States: results from a national survey. Am. Rev. Respir. Dis. 135:1007-1014.
120. Offer, R. C., A. G. Karlson, and J. A. Spittell, Jr. 1971. Infection caused by Mycobacterium fortuitum. Mayo Clin. Proc. 46:747-749.
121. Owen, M., A. Smith, and J. Coultras. 1963. Granulomatous lesions occurring at site of injections of vaccines and antibiotics. South. Med. J. 56:949-952.
122. Pacht, E. R. 1990. Mycobacterium fortuitum lung abscess: resolution with prolonged trimethoprim/sulfamethoxazole therapy. Am. Rev. Respir. Dis. 141:1599-1601.
123. Pappas, S. A., D. M. Schaaff, M. B. DiCostanzo, F. W. King, Jr., and J. T. Sharp. 1983. Contamination of flexible fiberoptic bronchoscopes. Am. Rev. Respir. Dis. 127:381-392.
124. Park, H., H. Jang, C. Kim, B. Chung, C. L. Chang, S. K. Park, and S. Song. 2000. Detection and identification of mycobacteria by amplification of the internal transcribed spacer regions with genus- and species-specific PCR primers. J. Clin. Microbiol. 38:4080-4085.
125. Patel, S., M. Yates, and N. A. Saunders. 1997. PCR-enzyme-linked immunosorbent assay and partial rRNA gene sequencing: a rational approach to identifying mycobacteria. J. Clin. Microbiol. 35:2375-2380.
126. Pattyn, S. R., M. Magnusson, J. L. Stanford, and J. M. Grange. 1974. A study of Mycobacterium fortuitum (ranae). J. Med. Microbiol. 7:67-76.
127. Pattyn, S. R., J. Vandepitte, F. Portaels, and A. De-Muynck. 1971. Cases of M. borstelense and M. abscessus infection observed in Belgium. J. Med. Microbiol. 4:145-149.
128. Peneau, A., D. Moinard, I. Berard, O. Pascal, and J. P. Moisan. 1992. Detection of mycobacteria using the polymerase chain reaction. Eur. J. Clin. Microbiol. Infect. Dis. 11:270-271.
129. Pennekamp, A., G. E. Pfjffer, J. Wüest, C. A. George, and C. Ruef. 1997. Mycobacterium smegmatis infection in a healthy woman following a facelift: case report and review of the literature. Ann. Plast. Surg. 39:80-83.
130. Perosio, P. M., and T. S. Frank. 1993. Detection and species identification of mycobacteria in paraffin sections of lung biopsy specimens by the polymerase chain reaction. Am. J. Clin. Pathol. 100:643-647.
131. Pettini, B., P. Hellstrand, and M. Erickson. 1980. Infection with M. chelonae following injections. Scand. J. Infect. Dis. 12:237-238.
132. Plaus, W. J., and G. Hermann. 1991. The surgical management of superficial infections caused by atypical mycobacteria. Surgery 110:99-103.
133. Plemmons, R. M., C. K. McAllister, D. A. Liening, and M. C. Garces. 1996. Otitis media and mastoiditis due to Mycobacterium fortuitum: case report, review of four cases, and a cautionary note. Clin. Infect. Dis. 22:1105-1106.
134. Pope, J., Jr., P. Sternberg, Jr., N. J. McLane, D. W. Potts, and R. D. Stulting. 1989. Mycobacterium chelonae scierai abscess after removal of a scierai buckle. Am. J. Ophthalmol. 107:557-558.
135. Pruitt, T. C., L. O. Hughes, R. D. Blasir, R. E. McCarthy, C. M. Glasier, and G. J. Roloson. 1993. Atypical mycobacterial vertebral osteomyelitis in a steroid-dependent adolescent. Spine 18:2553-2555.
136. Raad, I. I., S. Vartivarian, A. Khan, and G. P. Bodey. 1991. Catheter-related infections caused by the Mycobacterium fortuitum complex: 15 cases and review. Rev. Infect. Dis. 13:1120-1125.
137. Rappaport, W., G. Dunington, L. Norton, D. Ladin, E. Peterson, and J. Ballard. 1990. The surgical management of atypical mycobacterial soft-tissue infections. Surgery 108:36-39.
138. Reviglio, V., M. L. Rodriguez, G. S. Picotti, M. Paradello, J. D. Luna, and C. P. Juárez. 1998. Mycobacterium chelonae keratitis following laser in situ keratomileusis. J. Refrac. Surg. 14:357-360.
139. Ridell, M., and M. Goodfellow. 1983. Numerical classification of Mycobacterium farcinogenes, Mycobacterium senegalense and related taxa. J. Gen. Microbiol. 129:599-611.
140. Ringuet, H, C. Akoua-Kotfi, S. Honore, A. Varnerot, V. Vincent, P. Berche, J. L. Gaillard, and C. Pierre-Audigier. 1999. hsp65 sequencing for identification of rapidly growing mycobacteria. J. Clin. Microbiol. 37:852-857.
141. Rolston, K. V. I., P. G. Jones, V. Fainstein, and G. P. Bodey. 1985. Pulmonary disease caused by rapidly growing mycobacteria in patients with cancer. Chest 87:503-506.
142. Rootman, D. S., M. S. Insler, and D. E. Wolfley. 1989. Canaliculitis caused by Mycobacterium chelonae after lacrimal intubation with silicone tubes. Can. J. Ophthalmol. 24:221-222.
143. Roth, A., M. Fischer, M. E. Hamid, S. Michalke, W. Ludwig, and H. Mauch. 1998. Differentiation of phylogenetically related slowly growing mycobacteria based on 16S-23S rRNA gene internal transcribed spacer sequences. J. Clin. Microbiol. 36:139-147.
144. Roussel, T. J., W. H. Stern, D. F. Goodman, and J. P. Whitcher. 1989. Postoperative mycobacterial endophthalmitis. Am. J. Ophthalmol. 107:403-406.
145. Rubens, C. E., W. E. Farrar, Jr., Z. A. McGee, and W. Schaffner. 1981. Evolution of a plasmid mediating resistance to multiple antimicrobial agents during a prolonged epidemic of nosocomial infections. J. Infect. Dis. 143:170-181.
146. Runyon, H. 1972. Conservation of the specific epithet fortuitum in the name of the organism known as Mycobacterium fortuitum da Costa Cruz. Int. J. Syst. Bacteriol. 22:50-51.
147. Sack, J. B. 1990. Disseminated infection due to Mycobacterium fortuitum in a patient with AIDS. Rev. Infect. Dis. 12:961-963.
148. Safranek, T. J., W. R. Jarvis, L. A. Carson, L. B. Cusick, L. A. Bland, J. M. Swenson, and V. A. Silcox. 1987. Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution. N. Engl. J. Med. 317:197-201.
149. Saluja, A., N. T. Peters, L. Lowe, and T. M. Johnson. 1997. A surgical wound infection due to Mycobacterium chelonae successfully treated with clarithromycin. Dermatol. Surg. 23:539-543.
150. Samuel, J. J., G. Alangaden, and P. H. Chandrasekar. 2000. Cervical adenitis due to Mycobacterium fortuitum in a patient with AIDS. Infect. Dis. Clin. Pract. 9:221-222.
151. Sanguinetti, M., F. Ardito, E. Fiscarelli, M. La Sorda, P. D'Argenio, G. Ricciotti, and G. Fadda. 2001. Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis. J. Clin. Microbiol. 39:816-819.
152. Santamaría-Jaúregui, J., J. Sanz-Hospital, J. Berenguer, D. Mun̄oz, E. Gómez-Mampaso, and E. Bouza. 1984. Meningitis caused by Mycobacterium fortuitum. Am. Rev. Respir. Dis. 130:136-137.
153. Sarria, J. C., N. B. Chutkan, J. E. Figueroa, and A. Hull. 1998. Atypical mycobacterial vertebral osteomyelitis: case report and review. Clin. Infect. Dis. 26:503-505.
154. Schinsky, M. F., M. M. McNeil, A. M. Whitney, A. G. Steigerwalt, B. A. Lasker, M. M. Floyd, G. C. Hogg, D. J. Brenner, and J. M. Brown. 2000. Mycobacterium septicum sp. nov., a new rapidly growing species associated with catheter-related bacteraemia. Int. J. Syst. Evol. Microbiol. 50:575-581.
155. Schulze-Röbbecke, R., B. Janning, and R. Fischeder. 1992. Occurrence of mycobacteria in biofilm samples. Tubercle Lung Dis. 73:141-144.
156. Sexton, R. R. 1970. Mycobacterium fortuitum infection of the cornea, p. 25-28. In F. M. Polack (ed.), Corneal and external disease of the eye. Charles C Thomas, Springfield, Ill.
157. Shafran, S. D., and L. Chui. 2000. Erythema induratum as a form of active cutaneous tuberculosis: case and review. Infect. Dis. Clin. Pract. 9:33-36.
158. Silcox, V. A., R. C. Good, and M. M. Floyd. 1981. Identification of clinically significant Mycobacterium fortuitum complex isolates. J. Clin. Microbiol.14:686-691.
159. Smith, M. B., M. C. Boyars, and G. L. Woods. 1996. Fatal Mycobacterium fortuitum meningitis in a patient with AIDS. Clin. Infect. Dis. 23:1327-1328.
160. Smith, R. E., J. J. Salz, R. Moors, D. Silverstein, and W. Lewis. 1980. Mycobacterium chelonei and orbital granuloma after tear duct probing. Am. J. Ophthalmol. 89:139-141.
161. Soini, H., and M. K. Viljanen. 1997. Diversity of the 32-kilodalton protein gene may form a basis for species determination of potentially pathogenic mycobacterial species. J. Clin. Microbiol. 35:769-773.
162. Springer, B., E. C. Bōttger, P. Kirschner, and R. J. Wallace, Jr. 1995. Phylogeny of the Mycobacterium chelonae-like organism based on partial sequencing of the 16S rRNA gene and proposal of Mycobacterium mucogenicum sp. nov. Int. J. Syst. Bacteriol. 45:262-267.
163. Staneck, J. L., P. T. Frame, W. A. Altemier, and E. H. Miller. 1981. Infection of bone by Mycobacterium fortuitum masquerading as Nocardia asteroides. Am. J. Clin. Pathol. 76:216-222.
164. Stanford, J. L., and W. J. Gunthopre. 1969. Serological and bacteriological investigation of Mycobacterium ranae (fortuitum). J. Bacteriol. 98:375-383.
165. Stanford, J. L., S. R. Pattjn, F. Portaels, and W. J. Gunthorpe. 1972. Studies of Mycobacterium chclonei. J. Med. Microbiol. 5:177-182.
166. Steele, L. C., and R. J. Wallace, Jr. 1987. Ability of ciprofloxacin but not pipemidic acid to differentiate all three biovariants of Mycobacterium fortuitum from Mycobacterium chelonae. J. Clin. Microbiol. 25:456-457.
167. Steingrube, V. A., J. L. Gibson, B. A. Brown, Y. Zhang, R. W. Wilson, M. Rajagopalan, and R. J. Wallace, Jr. 1995. PCR amplification and restriction endonuclease analysis of a 65-kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria. J. Clin. Microbiol. 33:149-153.
168. Steingrube, V. A., R. J. Wallace, Jr., L. C. Steele, and D. R. Nash. 1991. Mercuric reductase activity and evidence of broad spectrum mercury resistance among clinical isolates of rapidly growing mycobacteria. Antimicrob. Agents Chemother. 35:819-823.
169. Stone, M. S., R. J. Wallace, Jr., J. M. Swenson, C. Thornsberry, and L. A. Christensen. 1983. Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics. Antimicrob. Agents Chemother. 24:486-493.
170. Stratford, S., R. Gonzalez-Rothi, M. Lauzardo, and A. Stecenko. 1992. A six-year cross-sectional study of mycobacterial infection in cystic fibrosis. Am. Rev. Respir. Dis. 145:A116.
171. Subbarao, E. K., M. M. Tarpay, and M. I. Marks. 1987. Soft-tissue infections caused by Mycobacterium fortuitum complex following penetrating injury. Am. J. Dis. Child. 141:1018-1020.
172. Sudesh, S., E. J. Cohen, L. W. Schwartz, and J. S. Myers. 2000. Mycobacterium chelonae infection in a comeal graft. Arch. Ophthalmol. 118:294-295.
173. Swenson, J. M., R. J. Wallace Jr., V. A. Silcox, and C. Thornsberry. 1985. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob. Agents Chemother. 28:807-811.
174. Takewaki, S. I., K. Okuzumi, I. Manabe, M. Tanimura, K. Miyamura, K. I. Nakahara, Y. Yazaki, A. Ohkubo, and R. Nagai. 1994. Nucleotide sequence comparison of the mycobacterial dnaJ gene and PCR-restriction fragment length polymorphism analysis for identification of mycobacterial species. Int. J. Syst. Bacteriol. 44:159-166.
175. Tebas, P., F. Sultan, R. J. Wallace, Jr., and V. Fraser. 1995. Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient. Clin. Infect. Dis. 20:443-444.
176. Telenti, A., F. Marchesi, M. Balz, F. Bally, E. C. Bōttger, and T. Bodmer. 1993. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J. Clin. Microbiol. 31:175-178.
177. Thibert, L., and S. LaPierre. 1993. Routine application of high-performance liquid chromatography for identification of mycobacteria. J. Clin. Microbiol. 31:1759-1763.
178. Tsang, A. Y., V. L. Barr, J. K. McClatchy, M. Goldberg, I. Drupa, and P. J. Brennan. 1984. Antigenic relationships of the Mycobacterium fortuitum-Mycobacterium chelonae complex. Int. J. Syst. Bacteriol. 34:35-44.
179. Tsukamura, M. 1966. Mycobacterium chitae, a new species. A preliminary report. Med. Biol. (Tokyo) 73:203-205. (In Japanese.)
180. Tsukamura, M. 1967. Mycobacterium chitae: a new species. Jpn. J. Microbiol. 11:43-47.
181. Tsukamura, M. 1972. Mycobacterium agri Tsukamura sp. nov. A new relatively thermophilic Mycobacterium. Med. Biol. (Tokyo) 85:153-156. (In Japanese.)
182. Tsukamura, M., H. Nemoto, and H. Yugi. 19S3. Mycobacterium porcinum sp. nov., a porcine pathogen. Int. J. Syst. Bacteriol. 33:162-165.
183. Vadakekalam, J., and M. J. Ward. 1991. Mycobacterium fortuitum lung abscess treated with ciprofloxacin. Thorax 46:737-738.
184. Vanecchoutte, M., H. De Beenhouner, G. Claejs, G. Verschraegen, A. De Rouck, N. Paepe, A. Elaichouni, and F. Portaels. 1993. Identification of Mycobacterium species using amplified ribosomal DNA restriction analysis. J. Clin. Microbiol. 31:2061-2065.
185. Varghese, G., R. Shepherd, P. Watt, and J. H. Bruce. 1988. Fatal infection with Mycobacterium fortuitum associated with esophagcal achalasia. Thorax 43:151-152.
186. Villaneuva, A., R. V. Calderon, B. A. Vargas, F. Ruiz, S. Aguero, Y. Zhang, B. A. Brown, and R. J. Wallace, Jr. 1997. Report on an outbreak of post-injection abscesses due to Mycobacterium abscessus, including management with surgery and clarithromycin therapy and comparison of strains by random amplified polymorphic DNA polymerase chain reaction. Clin. Infect. Dis. 24:1147-1153.
187. Vonmoos, S., P. H. Leuenberger, V. Beer, and R. de Halter. 1986. Infection pleuro-pulmonaire à Mycobacterium smegmatis. Schweiz. Med. Wochenschr. 116:1852-1856.
188. Wallace, R. J., Jr. 1989. The clinical presentation, diagnosis, and therapy of cutaneous and pulmonary infections due to the rapidly growing mycobacteria, M. fortuitum and M. chelonae. Clin. Chest Med. 10:419-429.
189. Wallace, R. J., Jr. 1996. Treatment of infections caused by rapidly growing mycobacteria in the era of the newer macrolides. Res. Microbiol. 147:30-35.
190. Wallace, R. J., Jr., G. Bedsole, G. Sumter, C. V. Sanders, L. C. Steele, B. A. Brown, J. Smith, and D. R. Graham. 1990. Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy. Antimicrob. Agents Chemother. 34:65-70.
191. Wallace, R. J., Jr., and B. A. Brown. 1999. Mycobacterium fortuitum, chelonae, abscessus, p. 372-379. In D. Schlossberg (ed.), Tuberculosis and nontuberculous mycobacterial infections. The W. B. Saunders Co., Philadelphia, Pa.
192. Wallace, R. J., Jr., B. A. Brown, and D. E. Griffith. 1998. Nosocomial outbreaks/pseudo-outbreaks caused by nontuberculous mycobacteria. Annu. Rev. Microbiol. 2:453-490.
193. Wallace, R. J., Jr., B. A. Brown-Elliott, L. Hall, G. Roberts, R. W. Wilson, L. B. Mann, C. J. Crist, S. H. Chiu, R. Dunlap, M. J. Garcia, J. T. Bagwell, and K. C. Jost, Jr. 2002. Clinical and laboratory features of Mycobacterium mageritensc. J. Clin. Microbiol. 40:2930-2935.
194. Wallace, R. J., Jr., A. Meier, B. A. Brown, Y. Zhang, P. Sander, G. O. Onyi, and E. C. Bōttger. 1996. Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob. Agents Chemother. 40:1676-1681.
195. Wallace, R. J., Jr., B. A. Brown, and G. Onji. 1991. Susceptibilities of Mycobacterium fortuitum biovar fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid. Antimicrob. Agents Chemother. 35:773-775.
196. Wallace, R. J., Jr., B. A. Brown, and G. Onji. 1992. Skin, soft tissue, and bone infections due to Mycobacterium chelonae subspecies chelonae-importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J. Infect. Dis. 166:405-412.
197. Wallace, R. J., Jr., B. A. Brown, V. A. Silcox, M. Tsukamura, D. R. Nash, L. C. Steele, V. A. Steingrube, J. Smith, G. Sumter, Y. Zhang, and Z. Blacklock. 1991. Clinical disease, drug susceptibility, and biochemical patterns of the unnamed third biovariant complex of Mycobacterium fortuitum. J. Infect. Dis. 163:598-603.
198. Wallace, R. J., Jr., B. A. Brown-Elliott, S. C. Ward, C. J. Crist, L. B. Mann, and R. W. Wilson. 2001. Activities of linezolid against rapidly growing mycobacteria. Antimicrob. Agents Chemother. 45:764-767.
199. Wallace, R. J., Jr., J. L. Cook, J. Glassroth, D. E. Griffith, K. N. Olivier, and F. Gordin. 1997. American Thoracic Society Statement: diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am. Respir. Crit. Care Med. 156:S1-S25.
200. Wallace, R. J., Jr., D. B. Jones, and K. Wiss. 1981. Sulfonamide activity against Mycobacterium fortuitum and Mycobacterium chelonei. Rev. Infect. Dis. 3:898-904.
201. Wallace, R. J., Jr., J. M. Musser, S. I. Hull, V. A. Silcox, L. C. Steele, G. D. Forrester, A. Labidi, and R. K. Selander. 1989. Diversity and sources of rapidly growing mycobacteria associated with infections following cardiac bypass surgery. J. Infect. Dis. 159:708-716.
202. Wallace, R. J., Jr., D. R. Nash, M. Tsukamura, Z. M. Blackock, and V. A. Silcox. 1988. Human disease due to Mycobacterium smeginalis. J. Infect. Dis. 158:52-59.
203. Wallace, R. J., Jr., V. A. Silcox, M. Tsukamura, B. A. Brown, J. O. Kilburn, W. R. Butler, and G. Onji. 1993. Clinical significance, biochemical features, and susceptibility patterns of sporadic isolates of the Mycobacterium chelonae-like organism. J. Clin. Microbiol. 31:3231-3239.
204. Wallace, R. J., Jr., L. C. Steele, A. Labidi, and V. A. Silcox. 1989. Heterogeneity among isolates of rapidly growing mycobacteria responsible for infections following augmentation mammaplasty despite case clustering in Texas and other southern coastal states. J. Infect. Dis. 160:281-288.
205. Wallace, R. J., Jr., J. M. Swenson, and V. A. Silcox. 1985. The rapidly growing mycobacteria: characterization and susceptibility testing. Antimicrob. Newsl. 2:85-92.
206. Wallace, R. J., Jr., J. M. Swenson, V. A. Silcox, and M. G. Bullen. 1985. Treatment of non-pulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. J. Infect. Dis. 152:500-514.
207. Wallace, R. J., Jr., J. M. Swenson, V. A. Silcox, and R. C. Good. 1982. Disk diffusion testing with polymyxin and amikacin for differentiation of Mycobacterium fortuitum and Mycobacterium chelonei J. Clin. Microbiol. 16:1003-1006.
208. Wallace, R. J., Jr., J. M. Swenson, V. A. Silcox, R. C. Good, J. A. Tschen, and M. S. Stone. 1983. Spectrum of disease due to rapidly growing mycobacteria. Rev. Infect. Dis. 5:657-679.
209. Wallace, R. J., Jr., D. Tanner, P. J. Brennan, and B. A. Brown. 1993. Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann. Intern. Med. 119:482-486.
210. Wallace, R. J., Jr., Y. Zhang, B. A. Brown, V. Fraser, G. H. Mazurek, and S. Maloney. 1993. DNA large restriction fragment patterns of sporadic and epidemic nosocomial strains of Mycobacterium chelonae and Mycobacterium abscessus. J. Clin. Microbiol. 31:2697-2701.
211. Wayne, L. G., and G. P. Kubica. 1986. Mycobacteria, p. 1435-1457. In P. H. A. Sneath (ed.), Bergey's manual of systematic bacteriology, vol. 2. The Williams & Wilkins Co, Baltimore, Md.
212. Wayne, L. G., and H. A. Sramek. 1992. Agents of newly recognized or infrequently encountered mycobacterial diseases. Clin. Microbiol. Rev. 5:1-25.
213. Wenger, J. D., J. S. Spika, R. W. Smithwick, V. Pryor, D. W. Dodson, G. A. Garden, and K. C. Klontz. 1990. Outbreak of Mycobacterium chelonae infection associated with use of jet injectors. JAMA 264:373-376.
214. Wheeler, P. W., D. Lancaster, and A. B. Kaiser. 1989. Bronchopulmonary cross-colonization and infection related to mycobacterial contamination of suction valves of bronchoscopes. J. Infect. Dis. 159:954-58.
215. Wilson, R. W., V. A. Steingrube, E. C. Böttger, B. Springer, B. A. Brown-Elliott, V. Vincent, K. C. Jost, Jr., Y. Zhang, M. J. Garcia, S. H. Chiu, G. O. Onji, H. Rossmoore, D. R. Nash, and R. J. Wallace, Jr. 2001. Mycobacterium immunogenum sp. nov., a novel species related to Mycobacterium abscessus and associated with clinical disease, pseudo-outbreaks, and contaminated metalworking fluids: an international cooperative study on mycobacterial taxonomy. Int. J. Syst. Evol. Microbiol. 51:1751-1764.
216. Wolinsky, E. 1979. Nontuberculous mycobacteria and associated diseases. Am. Rev. Respir. Dis. 119:107-159.
217. Wolinsky, E. 1992. Mycobacterial diseases other than tuberculosis. Clin. Infect. Dis. 15:1-12.
218. Wolinsky, E., and T. K. Rynearson. 1968. Mycobacteria in soil and their relation to disease-associated strains. Am. Rev. Respir. Dis. 97:1032-1037.
219. Woods, G. L., J. S. Bergmann, F. G. Witebsky, G. A. Fahle, B. Boulet, M. Flaunt, B. A. Brown, R. J. Wallace, Jr., and A. Wanger. 2000. Multisite reproducibility of Etest for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum. J. Clin. Microbiol. 38:656-661.
220. Woods, G. L., J. S. Bergmann, F. G. Witebsky, G. A. Fahle, A. Wanger, B. Boulet, M. Flaunt, B. A. Brown, and R. J. Wallace, Jr. 1999. Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum. J. Clin. Microbiol. 37:1676-1682.
221. Woods, G. L., B. A. Brown-Elliott, E. P. Desmond, G. S. Hall, L. Heifets, G. E. Pfyffer, M. R. Plaunt, J. C. Ridderhof, R. J. Wallace, Jr., N. G. Warren, and F. G. Witebsky. 2000. Susceptibility testing of mycobacteria, nocardia, and other aerobic actinomycetes; tentative standard 20:M24-T2, 2nd ed. NCCLS, Wayne, Pa.
222. Yakrus, M. A., S. M. Hernandez, M. M. Floyd, D. Sikes, W. R. Butler, and B. Metchock. 2001. Comparison of methods for identification of Mycobacterium abscessus and M. chelonae isolates. J. Clin. Microbiol. 39:4103-4110.
223. Yew, W. W., S. Y. L. Kwan, P. C. Wong, and J. Lee. 1990. Ofloxacin and imipenem in the treatment of Mycobacterium fortuitum and Mycobacterium chelonae lung infections. Tubercle 71:131-133.
224. Yew, W., P. Wong, H. Woo, C. Yip, C. Chan, and F. Cheng. 1993. Characterization of Mycobacterium fortuitum isolates from sternotomy wounds by antimicrobial susceptibilities, plasmid profiles, and ribosomal ribonucleic acid gene restriction patterns. Diagn. Microbiol. Infect. Dis. 17:111-117.
225. Zahid, M. A., S. A. Klotz, E. Goldstein, and W. Bartholomew. 1994. Mycobacterium chelonae (M. chelonae subspecies chelonae): report of a patient with a sporotrichoid presentation who was successfully treated with clarithromycin and ciprofloxacin. Clin. Infect. Dis. 18:999-1001.
226. Zenone, T., A. Boibieux, S. Tigaud, J.-F. Fredenucci, V. Vincent, and D. Peyramond. 1998. Nontuberculous mycobacterial tenosynovitis: report of two cases. Clin. Infect. Dis. 26:1467-1468.
227. Zhang, Y., M. Rajagopalan, B. A. Brown, and R. J. Wallace, Jr. 1997. Randomly amplified polymorphic DNA PCR for comparison of Mycobacterium abscessus strains from nosocomial outbreaks. J. Clin. Microbiol. 35:3132-3139.
228. Zhang, Y., R. J. Wallace Jr., V. A. Steingrube, B. A. Brown, D. R. Nash, A. Silcox, and M. Tsukamura. 1992. Isoelectric focusing patterns of β-lactamases in the rapidly growing mycobacteria. Tubercle Lung Dis. 73:337-344.
229. Zolg, J. W., and S. P. Schulz. 1994. The superoxide dismutase gene, a target for detection and identification of mycobacteria by PCR. J. Clin. Microbiol. 32:2801-2812.